Showing results (131-140 of 152) with videos related to
Sort By:
Pageof 16
Cancer Immunology, Immunotherapy : CII|January 3, 2021
Prognostic impact of primary cancer adjoining emphysematous bullae in non-small cell lung cancer patients treated with immune checkpoint inhibitorsShinkichi Takamori, Kazuki Takada, Mototsugu Shimokawa, et al.Journal of Cancer Research and Clinical Oncology|May 15, 2020
Expression of PD-L1, PD-L2, and IDO1 on tumor cells and density of CD8-positive tumor-infiltrating lymphocytes in early-stage lung adenocarcinoma according to histological subtypeKazuki Takada, Gouji Toyokawa, Fumihiko Kinoshita, et al.Anticancer Research|June 1, 2018
Radiological Features of Brain Metastases from Non-small Cell Lung Cancer Harboring <i>EGFR</i> MutationShinkichi Takamori, Gouji Toyokawa, Mototsugu Shimokawa, et al.Anticancer Research|October 3, 2018
PD-L2 Expression as a Potential Predictive Biomarker for the Response to Anti-PD-1 Drugs in Patients with Non-small Cell Lung CancerShinkichi Takamori, Kazuki Takada, Gouji Toyokawa, et al.Cancer Immunology, Immunotherapy : CII|July 13, 2020
Interleukin-38 promotes tumor growth through regulation of CD8<sup>+</sup> tumor-infiltrating lymphocytes in lung cancer tumor microenvironmentFumihiko Kinoshita, Tetsuzo Tagawa, Takaki Akamine, et al.International Journal of Cancer|March 15, 2021
Clinical impact of probiotics on the efficacy of anti-PD-1 monotherapy in patients with nonsmall cell lung cancer: A multicenter retrospective survival analysis study with inverse probability of treatment weightingKazuki Takada, Mototsugu Shimokawa, Shinkichi Takamori, et al.BMC Cancer|May 6, 2022
A propensity score-matched analysis of the impact of statin therapy on the outcomes of patients with non-small-cell lung cancer receiving anti-PD-1 monotherapy: a multicenter retrospective studyKazuki Takada, Mototsugu Shimokawa, Shinkichi Takamori, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2016
Patient-Derived Xenograft Establishment from Human Malignant Pleural MesotheliomaLicun Wu, Ghassan Allo, Thomas John, et al.Anticancer Research|December 27, 2017
Clinical Significance of PD-L1 Expression in Brain Metastases from Non-small Cell Lung CancerShinkichi Takamori, Gouji Toyokawa, Isamu Okamoto, et al.Journal of Thoracic Disease|December 31, 2015
Clinical role of a new prognostic score using platelet-to-lymphocyte ratio in patients with malignant pleural mesothelioma undergoing extrapleural pneumonectomyTetsuzo Tagawa, Masaki Anraku, Yosuke Morodomi, et al.Pageof 16